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Objectives: To evaluate the occurrence and clinical outcomes of Hepatitis C (HCV) 
patients co-infected with Human Immunodeficiency Syndrome (HIV) in a tertiary 
care hospital. MethOds: A retrospective study of the patients with clinical histories 
of HIV co-infection with HCV following HAART therapy in Infectious disease Unit at 
Hospital Palau Pinang (HPP), Malaysia from the year 2007 to 2012. The clinical and 
demographic data was collected from patient’s records. In present study we analyzed 
the collected data by using SPSS software (Version 20) to determine the correlation 
of variables and measure their infection rates in a particular population. Results: 
The study involves a total of 708 HIV infected patients with the mean age of 40 ± 
10.17 years together with 541(76.4%) males and 167(23.6%) females. There were 
130(18.4%) patients co-infected with HCV. The assigned population involve in cur-
rent study was Chinese 427(60.3%) followed by Indians 96(13.6%), Malay 151(21.3%) 
and minorities 34 (4.8%). There were three main modes of transmission including 
male heterosexual contact 506(71.5%), homosexual contact 47(6.6%) and intrave-
nous drug users (IVDU) 114(16.1%). The mean CD4 count, ALT and AST levels in 
HBV-HIV co-infected patients were 374 ± 150.65, 64 ± 76.15, 129 ± 61.06 respectively. 
The calculated result shows the significant association of several factors like sex 
(p = < 0.001), IVDU (p = < 0.001) with co-infection of HIV-HCV. The co-morbidities 
observed in the current study were Pulmonary Tuberculosis (23.6%), Pneumocystis 
pneumonia (14.4%), Hyperlipidemia (4.4%), Dyslipidemia (3.2%), Anemia (4.5%), 
Ischemic Heart Disease (2.5%), Diabetes Mellitus (8.2%), Hypertension (6.5%), 
Asthma (1.4%), Oral Candiasis (5.2%), Syphillus (3.1%), Liver Cirrohsis (1.1%), Cerebral 
Toxoplasmosis (2.3%), Virological Failure (1.1%). cOnclusiOns: The incidence rate 
of HCV among HIV individuals were about 18.4% including 76.4% males and 23.6% 
females. There was a significant correlation between HCV among HIV-positive 
patients depending on various variables like gender, age, exposure to risk factors. 
(p< 0.001).
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Objectives: Hand-hygiene amongst health care workers is amongst the most 
effective measures to reduce health care-associated infections, but compliance 
is often poor and little is known about the relative effectiveness of interventions 
to improve it. This study aimed to evaluate the effectiveness of hand-hygiene pro-
motion interventions and to study the association between levels of investment 
in interventions and improved compliance. MethOds: A search strategy was 
developed and electronic databases searched for studies published before March 
2014. Studies failing to meet the Cochrane Effective Practice and Organisation 
of Care Group (EPOC) inclusion criteria were rejected. Where studies had not 
used appropriate analytical methods, we re-analysed primary data. Information 
on resources required for interventions was extracted, and graded into three 
levels. Random effects meta-analysis was performed on studies considered 
sufficiently homogeneous with regard to interventions, participants and outcome 
measures. Results: Of 3,725 studies retrieved, 125 met inclusion criteria; 35 of 
these met EPOC criteria (6 randomised controlled trials (RCTs), 25 interrupted 
time-series (ITS), 2 controlled trials, and 2 controlled before-and-after studies). In 
four RCTs, hand-hygiene compliance was the primary outcome. Meta-analysis of 
these showed the intervention was associated with improved compliance (pooled 
odds ratio [OR], 1.39; 95%CI, 1.15-1.67, I2= 80.00%). Of the 13 ITS studies, 12 showed 
significant stepwise increases in hand-hygiene compliance. All but three of these 
also showed a post-intervention trend for increasing hand-hygiene compliance. 
Grouping studies by the level of investment, 22 were graded as resource-intensive 
while 11 and 2 studies had medium or low levels of investment, respectively. We 
found no evidence of a relationship between the level of investment and effect 
size. cOnclusiOns: Hand hygiene promotion has a positive impact on hand 
hygiene compliance, but evidence that increased investment in hand hygiene 
leads to larger improvements is lacking. Reporting on resources used for interven-
tions was, however, poor.
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Objectives: Varicella is a common, vaccine-preventable illness but its impact on 
public health in Asia-Pacific countries has received little attention. This study aimed 
to review the epidemiology and economic burden of varicella in Asia-Pacific coun-
tries. MethOds: A systematic literature review was conducted using PubMed and 
government web sites. Outcomes included epidemiology of varicella (incidence, 
mortality, and complication), vaccination policy and coverage, and varicella-related 
health care resource utilization and costs. Critical analyses of study quality and 
data gaps were performed. Results: Published data were identified from thirteen 
countries including Australia, China, India, Japan, Korea, Malaysia, New Zealand, 
Pakistan, Philippines, Singapore, Sri Lanka, Taiwan, and Thailand. No studies were 
identified for Indonesia and Vietnam. Publicly funded universal childhood vacci-
nation against varicella has been implemented in Australia, Korea, and Taiwan, 
while the remaining countries either recommend vaccination for only high-risk 
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Objectives: The aim of the current study is to explore and to observe the impact 
of cigarette smoking and alcohol use on adverse drug reactions occurrence 
of antiretroviral drugs among HIV/AIDS patients. MethOds: Retrospective 
analysis of all patients diagnosed with HIV infection and on HAART therapy 
from Jan 2007 to Dec 2012 was conducted at infections disease department 
of Hospital Pulau Pinang, Malaysia. Patient socio-demographic details along 
with clinical features were recorded and the susceptible ADRs were observed 
during the study period. Data was descriptively analyzed by using statistical 
package for social sciences (SPSS 20). Results: Out of 743 patients that under-
went HAART therapy, 314 (42.2%) patients had experienced adverse drug reac-
tions. Out of total included patients 571 (76.8%) were male and 172 (23.1%) were 
female. Among the patients, 512 (68.9%) were smokers and 340 (45.8%) patients 
were alcohol users. A total number of 425 (57.2%) adverse drug reactions were 
recorded of which 269 (63.2%) were reported among smokers and 162 (38.1%) 
were reported among alcohol users. Univariate analysis indicates a statistical 
significant relationship between the smoker (p-value = 0.009, 95% CI= 1.111 – 
2.079, Odd ratio= 1.520) and alcohol users (p-value= 0.008, 95% CI= 1.106 – 1.994, 
Odd ratio= 1.485) with the occurrence of adverse drug reactions on HAART in 
HIV patients. cOnclusiOns: The study indicates the incidence of adverse drug 
reactions is significant in smokers and alcohol users on HAART therapy. Patient 
counselling on avoiding smoking and alcohol consumption can reduce ADRs in 
patients on HAART therapy.
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Objectives: Current study is aimed to explore and to observe adverse drug reac-
tions occurrence of antiretroviral drugs among HIV/AIDS patients. MethOds: An 
observational retrospective study of all patients diagnosed of HIV infection and 
on HAART therapy from Jan 2007 to Dec 2012 was conducted at infectious disease 
department of Hospital Pulau Pinang, Malaysia. Patient socio-demographic details 
along with clinical features were recorded. The reported ADRs were assessed for 
causality by using Noranjo’s algorithm scale. Data was descriptively analyzed by 
using statistical package for social sciences (SPSS 20). Results: Out of 743 patients 
that underwent HAART therapy, 571 (76.8%) were male and 172 (23.1%) were female 
patients. Overall 314 (42.2%) patients had experienced adverse drug reactions. 
A total number of 425 (57.2%) adverse drug reactions were reported among which 
311 (73.1%) occurred in males and 114 (26.8%) in female patients. Lipodystrophy 
151 (35.5%) was the most common ADR reported; in male 126 (29.6%) and 
25 (5.8%) female patients were recorded. Lipodystrophy was followed by skin 
rashes 80 (18.8%) that included 56 (13.1%) male and 24 (5.7%) female patients. 
Anaemia was reported 74 (17.4%), of which 49 (11.5%) observed in male and 25 
(5.8%) female patients. A statistical significant relationship on Chi-square test 
was observed between the gender and the occurrence of adverse drug reactions 
(p-value = 0.002). However on univariate analysis the relationship between ADRs 
with gender resulted in insignificant value (p-value= 0.267, 95% CI= 0.862 – 1.712, 
Odd ratio= 1.215). cOnclusiOns: The study indicates the incidence of adverse 
drug reactions is higher in male than in female patients. However, a multicenter 
study with a large sample size may provide us with better understanding of this 
relationship.
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Objectives: To assess the prevalence and clinical outcomes of Hepatitis B 
(HBV) patients co-infected with Human Immunodeficiency Syndrome (HIV) 
in a tertiary care hospital. MethOds: A retrospective cross-sectional study 
was performed, of HBV positive HIV infected patients following HAART ther-
apy from 2007 to 2012 in Infectious disease Unit, Hospital Palau Pinang (HPP), 
Malaysia. The demographic and clinical data of the patients was collected ret-
rospectively. The collected data was analyzed with SPSS software (Version 20) 
to measure the correlation of variables and their infection rates. Results: A 
total of 664 HIV infected patients including 495 (74.5%) males and 169 (25.5%) 
females with mean age of 40 ± 10.35 years were included in present study. 
Of these, 86 (13%) were co-infected with HBV. The main race involved in cur-
rent study was Chinese 455 (68.5%) followed by Indians 88 (13.3%), Malay 83 
(12.5%) and minorities 38 (5.7%). The route of transmission was mainly male 
heterosexual contact 464 (69.9%) followed by homosexual 47(7.1%) and Intra-
Venous Drug Users (IVDU) 48 (7.2%). The mean CD4 count, ALT and AST lev-
els in HBV-HIV co-infected patients were 385 ± 148.55, 51.48 ± 39.42, 105.581 
± 38.37 respectively. The co-infection is significantly associated with gender 
(p = 0.05), and IVDU (p = 0.01). The co-morbidities seen in the present study 
were Pulmonary Tuberculosis (17.9%), Pneumocystis pneumonia (15.4%), 
Hyperlipidemia (4.1%), Dyslipidemia (4.1%), Anemia (5.1%), Ischemic Heart 
Disease (1.8%), Diabetes Mellitus (8.7%), Hypertension (6.9%), Asthma (1.5%), Oral 
Candiasis (5.6%), Syphillus (4.2%), Liver Cirrohsis (0.6%), Cerebral Toxoplasmosis 
(1.8%), Virological Failure (0.6%). cOnclusiOns: The overall prevalence of HBV 
among HIV patients were about 13% in which 74.5% was males while 25.5 % 
females. Raised levels of liver enzymes and lowered CD4 counts were seen in the 
co-infected patients. There was a significant correlation between co-infection 
with HBV among HIV patients depending on different variables.
